search
Back to results

Digitized Grip Strength

Primary Purpose

Rheumatoid Arthritis

Status
Unknown status
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Digitized sensor
Sponsored by
University Hospital, Montpellier
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Rheumatoid Arthritis

Eligibility Criteria

18 Years - 85 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Rheumatoid arthritis whatever its activity
  • Above 18 years old patients

Exclusion Criteria:

  • Other condition that may affect the level of fatigue and / or grip strength
  • Insufficient level of understanding to perform the measurement and self-report questionnaires

Sites / Locations

  • UH Montpellier

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

RA patients

Arm Description

Outcomes

Primary Outcome Measures

grip strength
Evaluate the correlation between the measurement of grip strength in the dominant hand measured by a digital sensor and activity of RA assessed by DAS 28

Secondary Outcome Measures

Full Information

First Posted
July 21, 2014
Last Updated
July 21, 2014
Sponsor
University Hospital, Montpellier
search

1. Study Identification

Unique Protocol Identification Number
NCT02197507
Brief Title
Digitized Grip Strength
Official Title
Evaluation of Grip Strength With Digitized Sensor in Adults With Rheumatoid Arthritis
Study Type
Interventional

2. Study Status

Record Verification Date
July 2014
Overall Recruitment Status
Unknown status
Study Start Date
September 2014 (undefined)
Primary Completion Date
September 2015 (Anticipated)
Study Completion Date
December 2015 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Montpellier

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Rheumatoid arthritis (RA) is the most common chronic inflammatory arthritis in adults. Monitoring of disease activity is based on Disease Activity Score 28 (DAS 28). There are also validated questionnaires for self-assessment of the disease by the patient. Grip strength measured using a digitized sensor used by the patient could be an additional tool to the remote monitoring of patients with RA. Main Objective : To evaluate the correlation between the measurement of grip strength in the dominant hand measured by a digital sensor and activity of RA assessed by DAS 28 Secondary objective : Evaluate the correlation between grip strength of the dominant hand and : scores of fatigue and pain (VAS and FACIT) the self-assessment scores known in RA : functional index Health Assessment Questionnaire (HAQ) and scores of activity RAPID3 and RADAI5. It is a cross-sectional study involving 150 patients followed in our department for RA. Grip strength of the dominant hand will be measured by a digitalized sensor during a single visit integrating into the routine monitoring of patients.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Rheumatoid Arthritis

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
150 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
RA patients
Arm Type
Experimental
Intervention Type
Device
Intervention Name(s)
Digitized sensor
Intervention Description
Measure of grip strength of the dominant hand
Primary Outcome Measure Information:
Title
grip strength
Description
Evaluate the correlation between the measurement of grip strength in the dominant hand measured by a digital sensor and activity of RA assessed by DAS 28
Time Frame
visit 1

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Rheumatoid arthritis whatever its activity Above 18 years old patients Exclusion Criteria: Other condition that may affect the level of fatigue and / or grip strength Insufficient level of understanding to perform the measurement and self-report questionnaires
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Christian Jorgensen, MD
Phone
04 67 33 72 31
Email
c-jorgensen@chu-montpellier.fr
Facility Information:
Facility Name
UH Montpellier
City
Montpellier
ZIP/Postal Code
34295
Country
France
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Christian Jorgensen, MD
Phone
04 67 33 72 31
Email
c-jorgensen@chu-montpellier.fr
First Name & Middle Initial & Last Name & Degree
Christian Jorgensen, MD
First Name & Middle Initial & Last Name & Degree
Pierre LEBLAY, MD
First Name & Middle Initial & Last Name & Degree
Rosanna Ferreira, MD
First Name & Middle Initial & Last Name & Degree
Yves Marie PERS, MD

12. IPD Sharing Statement

Learn more about this trial

Digitized Grip Strength

We'll reach out to this number within 24 hrs